Mr. Mavroudis is a professional portfolio manager specializing in institutional and private portfolios. He focuses on risk management, which is accompanied by in-depth financial market analysis (fundamental, macro and technical) to control the risk undertaken by the portfolios. He invests in all financial instruments globally (stocks, bonds, fx, commodities), restructuring investment portfolios based on prevailing conditions and the needs of each client-investor. Mr. Mavroudis has successfully navigated all ...

Core Insights - The article emphasizes the importance of a hybrid investment strategy that combines high-quality dividend stocks with other investment vehicles such as Business Development Companies, REITs, and Closed End Funds to enhance income while achieving total returns comparable to traditional index funds [1]. Investment Strategy - The company advocates for a balanced approach to investing, focusing on both growth and income to optimize investment returns [1]. - The strategy aims to create a solid base of classic dividend growth stocks, which can be supplemented with other asset classes to boost overall investment income [1]. Performance Comparison - The total return from this hybrid investment strategy is reported to be on par with the S&P 500 index, indicating its effectiveness in generating competitive returns [1].

PHOENIX, March 3, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of John Orlando as Managing Director of Life Sciences, based in Boston. Mr. Orlando, an established leader with over a decade of experience in venture lending, has built a strong reputation as a trusted partner within the Life Sciences industry. John Orlando, Managing Director of Life Sciences "We are thrilled to welcome John to our team," said ...

Trinity Capital Inc. (the "Company") cautions that this presentation may contain forward-looking statements that are based on current expectations and assumptions about future events, and which are not based in historical fact. The forward-looking statements in this presentation are based on current conditions as of the date of this presentation, and include, but are not limited to, statements regarding our financial objectives, beliefs, strategies, anticipated future operating results and cash flows, opera ...

Trinity Capital, Inc. (NASDAQ:TRIN) Q4 2024 Earnings Conference Call February 26, 2025 12:00 PM ET Company Participants Ben Malcolmson - Head, IR Kyle Brown - CEO, President, Chief Investment Officer & Director Michael Testa - CFO & Treasurer Gerald Harder - COO Ronald Kundich - Chief Credit Officer Conference Call Participants Matthew Hurwit - Jefferies Doug Harter - UBS Paul Johnson - KBW Christopher Nolan - Ladenburg Thalmann Operator Good morning. My name is David, and I will be your conference operator ...

Core Insights - Trinity Capital Inc. reported a record quarterly net investment income of $35 million, or $0.58 per share, for Q4 2024, and an annual net investment income of $116 million, or $2.20 per share [1][10] - The company achieved a total investment income growth of 31% year-over-year for 2024, with total investment income reaching $237.7 million [1][10] - The return on average equity (ROAE) for Q4 2024 was 17.4%, while the return on average assets (ROAA) was 7.6% [10] Fourth Quarter 2024 Highlights - Total investment income for Q4 2024 was $70.8 million, a 48.1% increase from $47.8 million in Q4 2023 [5][10] - Net investment income for Q4 2024 was approximately $34.6 million, compared to $25.1 million in Q4 2023 [8][10] - The effective yield on average debt investments at cost was 16.4% for Q4 2024, slightly down from 16.7% in Q4 2023 [5] Full Year 2024 Highlights - Total gross investments funded for the year reached $1.2 billion, marking a 91.6% increase year-over-year [10] - The net asset value (NAV) at the end of Q4 2024 was $823 million, or $13.35 per share, up from $611 million at the end of 2023 [12][10] - The company maintained its 20th consecutive quarter of consistent or increased regular dividends, with a distribution of $0.51 per share for Q4 2024 [10][22] Portfolio and Investment Activity - As of December 31, 2024, the investment portfolio had a fair value of approximately $1.73 billion, with $1.29 billion in secured loans [13][10] - The company originated approximately $410.6 million in new commitments during Q4 2024 [14][10] - Total investment exits and repayments during the quarter amounted to approximately $280.6 million [15][10] Liquidity and Capital Resources - As of December 31, 2024, the company had approximately $496.6 million in available liquidity, including $9.6 million in unrestricted cash [18][10] - The KeyBank Credit Facility was expanded to $600 million during the quarter [20][10] - The company's leverage ratio was approximately 108% at the end of Q4 2024, down from 122% at the end of Q3 2024 [21][10]

Financing Activities - Trinity Capital completed a private equity offering, issuing 8,333,333 shares for approximately $125.0 million in gross proceeds[17]. - The company also completed a private debt offering of $125.0 million in unsecured 7.00% Notes due 2025[18]. - The company has established a joint venture to co-manage investments in secured loans and equipment financings to growth-stage companies[22]. - The company has established relationships with major technology banks to facilitate seamless collaboration in investment opportunities[63]. - A share repurchase program has been authorized for up to $30 million over 12 months, but there is no assurance that it will enhance long-term stockholder value[152]. Investment Strategy - Trinity Capital targets investments in growth-oriented companies with expected annual revenues of up to $100 million, which are often underserved by traditional lenders[26]. - The company's loans and equipment financings generally range from $5 million to $50 million, limiting each to approximately 5% or less of total assets[29]. - Trinity Capital's investment strategy includes obtaining warrants or contingent exit fees from portfolio companies, providing additional potential returns[25]. - The company seeks to invest in a diverse range of industries and geographic regions, not limited to any specific sector[53]. - The company aims to provide portfolio companies with access to growth capital that may only be available through incremental equity investments[49]. Market Conditions and Risks - The annual venture debt market in the U.S. surpassed $30 billion for the fourth consecutive year in 2024, indicating significant growth opportunities[43]. - The demand for loans and equipment financings for growth-oriented companies is estimated to be 20% to 30% of annual venture equity investment activity[47]. - The financing products offered by traditional lenders often impose restrictive covenants, making them less attractive to growth-oriented companies[46]. - The company faces risks related to changes in interest rates and inflation rates, which could impact its financial condition and results of operations[114]. - Economic conditions, including fluctuations in demand for equipment, interest rates, and inflation rates, pose risks that could threaten the ability to operate profitably[165]. Regulatory Compliance - The company is classified as an emerging growth company and plans to utilize reduced disclosure requirements under the JOBS Act for up to five years following its IPO[78]. - The company has elected to be regulated as a Business Development Company (BDC) under the 1940 Act, which imposes specific restrictions on transactions and requires a majority of independent directors[80]. - To qualify as a BDC, at least 70% of the company's total assets must consist of qualifying assets, with a significant focus on investments in eligible portfolio companies[82]. - The company must maintain an asset coverage ratio of at least 150%, allowing it to borrow $2 for every $1 of investor equity[89]. - The company intends to qualify as a Regulated Investment Company (RIC) for U.S. federal income tax purposes, which would exempt it from federal income tax on distributed income[95]. Portfolio Management and Valuation - The company has developed a proprietary credit rating system to evaluate and underwrite prospective portfolio companies[40]. - The company's debt investment portfolio had a weighted average risk rating score of 2.9 as of December 31, 2024[75]. - A significant portion of the company's portfolio investments will be recorded at fair values determined by the Board, leading to uncertainty in valuation[148]. - The Board will adjust quarterly the valuation of the portfolio, with changes recorded as net change in unrealized gain or loss on investments[151]. - The company expects most of its investments to be classified as Level 3 in the fair value hierarchy, indicating reliance on unobservable inputs and significant management judgment[150]. Competitive Landscape - The company operates in a highly competitive market for investment opportunities, which could reduce returns and result in losses[122]. - A significant part of the company's competitive advantage lies in the underserved market for investments in small, fast-growing private companies, but increased competition could force less attractive investment terms[124]. - The equipment financing industry is highly competitive, with significant pressure on financing rates and resale prices due to competition from financial institutions and leasing companies[163]. - The company may face conflicts of interest due to managing other investment funds that operate in the same line of business[156]. - The company relies on strong referral relationships with venture capital sponsors for deal flow, and failure to maintain these relationships could adversely affect its business[114]. Financial Performance and Distributions - The company must distribute at least 90% of its investment company taxable income annually[96]. - The company may have difficulty paying required distributions if it recognizes income before receiving cash representing such income[118]. - If expenses exceed investment company taxable income, the company may experience a net operating loss for the year, which cannot be carried forward[103]. - The company may be subject to U.S. federal income tax at corporate rates if it fails to qualify as a RIC, impacting its ability to make distributions[105]. - The company must meet certain "asset coverage" tests to make distributions while debt obligations are outstanding, or it risks failing to qualify for tax treatment as a RIC[101]. Investment Risks - The company faces competitive pressures that may adversely affect its financial condition, results of operations, and cash flows, potentially leading to decreased net interest income and increased credit loss risk[123]. - The company may need to refinance its indebtedness, and market conditions could affect the ability to do so on favorable terms[139]. - Defaults under credit facilities could force the company to sell investments at disadvantageous prices, negatively impacting financial condition and results[143]. - The company may face limitations on how borrowed funds can be used, which could restrict operational flexibility and growth potential[142]. - The company may face significant risks in the Finance and Insurance industry due to complex federal and state laws and potential regulatory restrictions[195].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2025 TRINITY CAPITAL INC. (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: (Exact name of Registra ...

Group 1: Investment Announcement - Trinity Capital Inc. has committed $15 million in growth capital to Cagent Vascular Inc., which is a significant addition to the $45 million equity financing led by US Venture Partners in 2024 [1][4] - This investment aims to support Cagent Vascular's innovative vascular treatment technologies, particularly their flagship product, Serranator®, which enhances angioplasty procedures [2][4] Group 2: Company Overview - Cagent Vascular Inc. specializes in developing advanced endovascular solutions to improve patient outcomes in minimally invasive interventions, particularly for peripheral artery disease [2][6] - The company's Serration technology has been utilized in over 20,000 procedures, demonstrating a growing body of clinical evidence supporting its effectiveness [4][6] Group 3: Strategic Partnership - Trinity Capital expresses excitement about partnering with Cagent Vascular to expand their platform of solutions for treating peripheral artery disease [3][4] - Cagent Vascular's leadership emphasizes the importance of this additional capital in scaling their commercial infrastructure and accelerating clinical adoption of their technologies [4]

Core Insights - Trinity Capital Inc. announced preliminary estimates for its financial results for Q4 and the full year ended December 31, 2024, indicating a strong performance in net investment income and asset valuation [1][2] Financial Estimates - The preliminary estimate of net investment income for Q4 2024 is projected to be between $0.58 and $0.60 per share [2] - The estimated net asset value per share as of December 31, 2024, is expected to be in the range of $13.32 to $13.37 [2] - The estimated investment assets at fair value as of December 31, 2024, are approximately $1.7 billion [2] - Investments on non-accrual status are estimated to comprise about 0.8% of the total debt investment portfolio at fair value and approximately 2.6% at cost as of December 31, 2024 [2] Conference Call Information - A conference call to discuss the financial results will be held on February 26, 2025, at 12:00 p.m. Eastern Time [3] Company Overview - Trinity Capital Inc. is an international alternative asset manager focused on providing stable returns through access to the private credit market, investing in growth-oriented companies [4]